These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18363719)

  • 1. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
    Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
    Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
    Perbellini O; Zamò A; Colarossi S; Zampieri F; Zoppi F; Bonadonna P; Schena D; Artuso A; Martinelli G; Chilosi M; Pizzolo G; Zanotti R
    Cytometry B Clin Cytom; 2011 Nov; 80(6):362-8. PubMed ID: 21656905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
    Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
    Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
    Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
    Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.
    van Daele PL; Beukenkamp BS; Geertsma-Kleinekoort WM; Valk PJ; van Laar JA; van Hagen PM; van der Velden VH
    Neth J Med; 2009 Apr; 67(4):142-6. PubMed ID: 19581658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
    Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
    Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.
    Cherian S; McCullouch V; Miller V; Dougherty K; Fromm JR; Wood BL
    Cytometry B Clin Cytom; 2016 Jul; 90(4):387-92. PubMed ID: 26525770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
    Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
    Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis.
    Nwogbo OV; Fang H; Wang W; Xu J; Miranda RN; Bose P; Ok CY; Jorgensen JL; Medeiros LJ; Wang SA
    Am J Clin Pathol; 2024 Jun; 161(6):598-608. PubMed ID: 38372648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
    Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
    J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
    Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
    Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
    Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.